News
Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with Johnson & Johnson’s botched acquisition of Guidant, a medical device company, in 2004. By David Gelles DealBook ...
Boston College continues to build up the trenches in their 2026 class of recruits, adding offensive tackle Lawrence Iyalekhue from Yonkers, New York. This pushes BC's Class of 2026 to 23 total ...
The logo that was posted on Monday resembled that of which the Bruins used from 1949 to 1995, and was brought back with slight modifications for the franchise's 100th season in 2023-24.
The Bruins used this logo with the yellow “B” in the middle for nearly 40 years before switching to the black logo they have been using for nearly three decades now. The blast from the past ...
The Bruins unveiled the new logo on Monday in a video and photos posted to social media. The rebrand shows both a yellow B on ...
This week has been a big one for the Boston Bruins. They unveiled a retooled logo on June 23 and teased about a possible change to their jersey for the 2025-26 NHL season. The following day ...
This week has been a big one for the Boston Bruins. They unveiled a retooled logo on June 23 and teased about a possible change to their jersey for the 2025-26 NHL season.
The Trump administration’s decision to bomb nuclear sites in Iran is largely simplified by the United States’ inability to prevent North Korea from becoming a nuclear state – an effort ...
Abstract People are involved with the collection and curation of all biodiversity data, whether they are researchers, members of the public, taxonomists, conservationists, collection managers or ...
When assessing Boston Scientific’s valuation against the S&P 500, the stock presents as notably expensive across key metrics. The company’s price-to-sales (P/S) ratio stands at 8.3 ...
Boston College's busy spring continues on Wednesday as Bill O'Brien and his staff will host their annual 7v7 tournament in the Fish Fieldhouse. Teams from around the northeast will come to compete ...
As of June 30, 2025, Boston Scientific Corporation (BSX) has a price-earnings ratio of 78.4. Boston Scientific Corporation has a price-to-sales ratio of 9.01. Their price-to-book-value ratio is 7.15.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results